Ingevity (NGVT) Stock Price, News & Analysis

Company Overview

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications. The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, paper chemicals, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It serves automotive parts and components manufacturers through sales representatives and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.

Key Stats

• Today's Range: $43.35 to $44.48
• 50-Day Range: $31.59 to $50.21
• 52-Week Range: $30.90 to $56.29
• Volume: 51,453 shs
• Average Volume: 263,999 shs
• Market Capitalization: $1.59 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $52.17
• Consensus Rating: Moderate Buy

Ingevity Stock Analysis - MarketRank™

Ingevity scored higher than 64% of companies evaluated by MarketBeat, and ranked 111th out of 197 stocks in the basic materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Ingevity has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 3 buy ratings, 3 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Ingevity has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 35.29%

Earnings Growth

Earnings for Ingevity are expected to grow by 35.29% in the coming year, from $2.55 to $3.45 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Ingevity is -2.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Ingevity is -2.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Ingevity has a P/B Ratio of 2.49. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.95% of the float of Ingevity has been sold short.

Short Interest Ratio / Days to Cover

Ingevity has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Ingevity has recently decreased by 10.17%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Ingevity does not currently pay a dividend.

Dividend Growth

Ingevity does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

2.95% of the float of Ingevity has been sold short.

Short Interest Ratio / Days to Cover

Ingevity has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Ingevity has recently decreased by 10.17%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.2 / 5
• News Sentiment: 0.80

News Sentiment

Ingevity has a news sentiment score of 0.80. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.43 average news sentiment score of Basic Materials companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for Ingevity this week, compared to 3 articles on an average week.

Search Interest

1 people have searched for NGVT on MarketBeat in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Ingevity insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 1.10% of the stock of Ingevity is held by insiders.

Percentage Held by Institutions

91.59% of the stock of Ingevity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

NGVT Stock Analysis - Frequently Asked Questions

How have NGVT shares performed this year?

Ingevity's stock was trading at $47.22 on January 1st, 2024. Since then, NGVT shares have decreased by 8.1% and is now trading at $43.40.
View the best growth stocks for 2024 here.

How were Ingevity's earnings last quarter?

Ingevity Co. (NYSE:NGVT) issued its quarterly earnings results on Tuesday, October, 29th. The company reported $1.10 EPS for the quarter, beating analysts' consensus estimates of $0.60 by $0.50. Ingevity's revenue was down 15.5% on a year-over-year basis.

Who are Ingevity's major shareholders?

Ingevity's top institutional shareholders include Wellington Management Group LLP (5.84%), State Street Corp (4.26%), Thrivent Financial for Lutherans (3.80%) and Segall Bryant & Hamill LLC (3.26%). Insiders that own company stock include Stuart Edward Jr Woodcock, Erik Spencer Ripple, Richard Allen White Jr and Phillip John Platt.
View institutional ownership trends.

How do I buy shares of Ingevity?

Shares of NGVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Ingevity own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Ingevity investors own include American Water Works (AWK), Waste Connections (WCN), DiamondRock Hospitality (DRH), Humana (HUM), AUO (AUOTY), The RMR Group (RMR) and Voyager Therapeutics (VYGR).

Company Calendar

• Last Earnings: 10/29/2024
• Today: 12/18/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Basic Materials
• Industry: Chemicals & allied products
• Sub-Industry: Chemicals
• Current Symbol: NYSE:NGVT
• Previous Symbol: NASDAQ:NGVT
• CUSIP: N/A
• CIK: 1653477
• Web: www.ingevity.com
• Phone: (843) 740-2300
• Fax: 843-740-8165
• Employees: 1,700
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $52.17
• High Stock Price Target: $62.00
• Low Stock Price Target: $40.00
• Potential Upside/Downside: +18.6%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 6 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($15.53)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 17.25
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: -38.11%
• Pretax Margin: -47.21%
• Return on Equity: 24.46%
• Return on Assets: 4.29%

Debt

• Debt-to-Equity Ratio: 6.52
• Current Ratio: 1.76
• Quick Ratio: 1.04

Sales & Book Value

• Annual Sales: $1.48 billion
• Price / Sales: 1.08
• Cash Flow: $6.91 per share
• Price / Cash Flow: 6.37
• Book Value: $17.43 per share
• Price / Book: 2.52

Miscellaneous

• Outstanding Shares: 36,349,000
• Free Float: 35,949,000
• Market Cap: $1.60 billion
• Optionable: Optionable
• Beta: 1.62